Further Evidence of Neuroprotection of Simvastatin in Parkinson’s

Related Articles:

• Current status and potential role of circular RNAs in neurological disorders. May 18, 2019 Related ArticlesCurrent status and potential role of circular RNAs in neurological disorders. J Neurochem. 2019 May 16;: Authors: Lu S, Yang X, Wang C, Chen S, Lu S, Yan W, Xiong K, Liu F, Yan J Abstract Given the importance of non-coding RNAs in modulating normal brain functions and their implications in the treatment of neurological disorders, non-coding RNA-based diagnostic…
• Astrocytes to Dopamine Neurons in One Step June 25, 2020 Parkinson's is a neurodegenerative condition, resulting in the loss of specific types of nerve cells from the brain. The 'motor symptoms' of Parkinson's are associated with a reduction in the number of these nerve cells (or neurons) that produce the chemical 'dopamine' in the mid-brain. For a long time, researchers have been experimenting with different methods to replace these lost…
• Astrocytes to Dopamine Neurons in One Step June 25, 2020 Parkinson's is a neurodegenerative condition, resulting in the loss of specific types of nerve cells from the brain. The 'motor symptoms' of Parkinson's are associated with a reduction in the number of these nerve cells (or neurons) that produce the chemical 'dopamine' in the mid-brain. For a long time, researchers have been experimenting with different methods to replace these lost…
• Astrocytes to Dopamine Neurons in One Step June 25, 2020 Parkinson's is a neurodegenerative condition, resulting in the loss of specific types of nerve cells from the brain. The 'motor symptoms' of Parkinson's are associated with a reduction in the number of these nerve cells (or neurons) that produce the chemical 'dopamine' in the mid-brain. For a long time, researchers have been experimenting with different methods to replace these lost…
• Dopamine Replacement Cell Therapies - Research Updates April 1, 2019 Stem Cell Therapies for Parkinson's Although the underlying cause of Parkinson's is unknown, scientists do know that Parkinson's results from the impairment and loss of dopamine producing cells in an area of the brain called the substantia nigra. It stands to reason therefore that replacement of those cells is a viable and potentially potent treatment method. Although it is acknowledged…
• Dopamine Cell Replacement Therapies - Research Updates May 9, 2019 YouTube Video https://www.youtube.com/watch?v=fOa21v8MpGw Stem Cell Therapies for Parkinson's Although the underlying cause of Parkinson's is unknown, scientists do know that Parkinson's results from the impairment and loss of dopamine producing cells in an area of the brain called the substantia nigra. It stands to reason therefore that replacement of those cells is a viable and potentially potent treatment method. Although…
• Dopamine Cell Replacement Therapies - Research Updates May 15, 2019 YouTube Video https://www.youtube.com/watch?v=fOa21v8MpGw Stem Cell Therapies for Parkinson's Although the underlying cause of Parkinson's is unknown, scientists do know that Parkinson's results from the impairment and loss of dopamine producing cells in an area of the brain called the substantia nigra. It stands to reason therefore that replacement of those cells is a viable and potentially potent treatment method. Although…
• Stem Cell (Dopamine Cell Replacement) Therapies For Parkinson's July 24, 2019 YouTube Video https://www.youtube.com/watch?v=fOa21v8MpGw Stem Cell Therapies for Parkinson's Although the underlying cause of Parkinson's is unknown, scientists do know that Parkinson's results from the impairment and loss of dopamine producing cells in an area of the brain called the substantia nigra. It stands to reason therefore that replacement of those cells is a viable and potentially potent treatment method. Although…
• Dopamine Triggers Movement but Does Not Sustain It, Parkinson’s Study Suggests February 13, 2018 The neurotransmitter dopamine sparks movement, but does not sustain it, according to a Portuguese and American study with implications for the development of Parkinson’s therapies. A feature of Parkinson’s disease is the death of dopamine-producing nerve cells in an area of the brain called the substantia nigra. Dopamine is a signaling molecule that plays a key role in generating movement.…
• Protein Mediates Nerve Cells’ Susceptibility to Neurotoxins, Mouse Study Finds March 28, 2018 A protein found on the surface of cells mediates nerve cells’ susceptibility to damage and death. This discovery may open new therapeutic avenues to prevent neuron degeneration associated with Parkinson’s disease. The study, “Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson’s disease,” was published in PlosOne.  Only 10 percent of Parkinson’s disease cases are…
• Parkinson’s Patients Show Elevated Levels of Specific Protein in Key Brain Area, Study Reports August 29, 2018 Alterations in certain types of fat in a brain area called the substantia nigra may result in elevated levels of the GPNMB protein and drive neurodegeneration in Parkinson’s disease patients, according to Harvard researchers. The study, titled “The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson’s disease patients and increases after lysosomal stress,” appeared in the journal Neurobiology of Disease. The GPNMB…
• Parkinson’s Patients Show Elevated Levels of Specific Protein in Key Brain Area, Study Reports August 29, 2018 Alterations in certain types of fat in a brain area called the substantia nigra may result in elevated levels of the GPNMB protein and drive neurodegeneration in Parkinson’s disease patients, according to Harvard researchers. The study, titled “The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson’s disease patients and increases after lysosomal stress,” appeared in the journal Neurobiology of Disease. The GPNMB…
• Researchers “stunned” by study that raises hopes for Parkinson’s treatment July 2, 2020 A new study reprogramming cells to replace reduced dopamine neurons in the brain could be used to reverse symptoms of Parkinson’s and other neurological conditions. As part of the study – conducted by the University of California San Diego (UCSD) – researchers found a way to convert star-shaped brain cells called astrocytes into cells producing dopamine. The team used the…
• Tiny Crystals May Help Scientists Trace Causes of Brain Inflammation in Parkinson’s, Study Reports November 21, 2019 Tiny and traceable man-made crystals, known as quantum dots, may be useful in carrying toxins to select cells in the brain, allowing researchers to better understand Parkinson’s neurodegenerative processes by being able to model and visualize them, researchers in Canada report. Their study, “Quantum dot conjugated saporin activates microglia and induces selective substantia nigra degeneration,” was published in NeuroToxicology. Microglia,…
• Tiny Crystals May Help Scientists Trace Causes of Brain Inflammation in Parkinson’s, Study Reports November 21, 2019 Tiny and traceable man-made crystals, known as quantum dots, may be useful in carrying toxins to select cells in the brain, allowing researchers to better understand Parkinson’s neurodegenerative processes by being able to model and visualize them, researchers in Canada report. Their study, “Quantum dot conjugated saporin activates microglia and induces selective substantia nigra degeneration,” was published in NeuroToxicology. Microglia,…
• Genetic Manipulators of Alpha Synuclein November 25, 2019 In the brains of people with Parkinson's, there is an accumulation of alpha synuclein protein. It clusters and aggregates together forming dense circular objects inside neurons called Lewy bodies. This build up of alpha synuclein is believed to play a role in the neurodegeneration associated with Parkinson's. Researchers have previously conducted large screening studies to identify genes that could be…
• Mitochondria Defects in Brains of Parkinson’s Patients Might Play Protective Role January 18, 2018 Defects in mitochondria, the cell’s microscopic powerhouses, might actually protect Parkinson’s disease patients, a Norwegian study suggests. The findings show that, contrary to all current theories, deficiencies in complex I — a key component of mitochondria — exist randomly throughout the brains of Parkinson’s patients, not only in affected regions. In addition, researchers think these deficiencies protect against the formation of…
• Measuring Levels of Critical Protein May Aid Earlier Diagnosis of Parkinson’s March 2, 2018 A new way to measure levels of a critical protein in Parkinson’s disease could lead to improved diagnosis and treatments. Using a positron emission tomography (PET) imaging camera, Swedish researchers were able to measure  levels of a protein called dopamine transporter (DAT) as a way to investigate the dopamine system in the brains of patients who have Parkinson’s disease. The research, “Nigrostriatal dopamine…
• Breakthrough in stem cell treatment for Parkinson's February 25, 2018 In a major breakthrough for the treatment of Parkinson's disease, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain, replacing the cells lost to the disease. Researchers say it is possible to make dopamine cells from human embryonic stem cells, paving the way for a new…
• Breakthrough in stem cell treatment for Parkinson's February 25, 2018 In a major breakthrough for the treatment of Parkinson's disease, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain, replacing the cells lost to the disease. Researchers say it is possible to make dopamine cells from human embryonic stem cells, paving the way for a new…